NASDAQ · XSPA
Consumer Cyclical · Personal Products & Services
$0.66
Down-$0.04 (-5.65%)
Updated Aug 23, 2026, 8:46 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
XSPA does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning XSPA.
XSPA research
Company profile and research snapshot.
XpresSpa Group, Inc., a health and wellness services company, provides spa services at airports. It operates through three segments: XpresSpa, XpresTest, and Treat. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as FORM Holdings Corp. and changed its name to XpresSpa Group, Inc. in January 2018. XpresSpa Group, Inc. is headquartered in New York, New York.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 18, 2022 | HC Wainwright & Co. | Buy | — |
| Nov 17, 2021 | HC Wainwright & Co. | Buy | — |
| Feb 16, 2021 | HC Wainwright & Co. | Buy | — |
No generated briefing is available yet.
Zacks Investment Research · Aug 15, 2022
XpresSpa Group, Inc. (XSPA) delivered earnings and revenue surprises of 20% and 1.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewswire Inc. · Aug 12, 2022
Resurgence of Travel Sees Surge in Demand of Airport Self-care Solutions and Amenities for Passengers Resurgence of Travel Sees Surge in Demand of Airport Self-care Solutions and Amenities for Passengers
Zacks Investment Research · Aug 11, 2022
Armata Pharmaceuticals, Inc. (ARMP) delivered earnings and revenue surprises of 0% and 98.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewswire Inc. · Aug 10, 2022
Webcast and Conference Call Scheduled for 4:30 PM ET Webcast and Conference Call Scheduled for 4:30 PM ET
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning XSPA.
No results
No recent SID articles mention XSPA.
